Narcolepsy Trial, Recruiting (NCT07365566)

Narcolepsy Trial, Recruiting NCT07365566 Sponsor: University Hospital, Toulouse Condition: Narcolepsy

Printed from Voxsanity (voxsanity.com.au) — NCT07365566 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Narcolepsy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Main participant group:

You have been diagnosed with a sleep condition called iRBD (a disorder where you act out your dreams during sleep), confirmed by an overnight sleep study
You have not been diagnosed with Parkinson's disease or any other brain-degenerating condition
You are able to understand and complete the study tasks and questionnaires

Control group (comparison group):

You have been diagnosed with a specific sleep disorder called narcolepsy type 1
You also have a dream-acting sleep disorder (REM sleep behavior disorder), confirmed by an overnight sleep study
You are able to understand and complete the study tasks and questionnaires

Who may not be able to join:

You have been diagnosed with Parkinson's disease, dementia with Lewy bodies, or multiple system atrophy (types of conditions affecting the brain and nervous system)
You have been diagnosed with severe depression based on recognised medical guidelines
You are unable to complete the study tasks or questionnaires for any reason

Important: Always verify eligibility with the trial site directly before applying.

Note: This information is provided for general understanding only and does not constitute medical advice. Only the trial team can confirm whether you are eligible to participate.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 05 61 77 60 39

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07365566

Sponsor: University Hospital, Toulouse

Phase: Not Applicable

Status: Recruiting

Condition: Narcolepsy

Trial contact: 05 61 77 60 39

More information: https://clinicaltrials.gov/study/NCT07365566

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Main participant group:

You have been diagnosed with a sleep condition called iRBD (a disorder where you act out your dreams during sleep), confirmed by an overnight sleep study
You have not been diagnosed with Parkinson's disease or any other brain-degenerating condition
You are able to understand and complete the study tasks and questionnaires

Control group (comparison group):

You have been diagnosed with a specific sleep disorder called narcolepsy type 1
You also have a dream-acting sleep disorder (REM sleep behavior disorder), confirmed by an overnight sleep study
You are able to understand and complete the study tasks and questionnaires

Who may not be able to join:

You have been diagnosed with Parkinson's disease, dementia with Lewy bodies, or multiple system atrophy (types of conditions affecting the brain and nervous system)
You have been diagnosed with severe depression based on recognised medical guidelines
You are unable to complete the study tasks or questionnaires for any reason

Important: Always verify eligibility with the trial site directly before applying.

Note: This information is provided for general understanding only and does not constitute medical advice. Only the trial team can confirm whether you are eligible to participate.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University Hospital, Toulouse

Registry

ClinicalTrials.gov

Start date

24 February 2026

Est. completion

1 August 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Comparison of the intensity of chronic pain between patients with iRBD and a control group of patients

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov